Bristol-Myers Squibb: Is It Time To Buy Bristol Myers Squibb Stock?

Bristol Myers Squibb (NYSE:BMY) recently reported its first-quarter results, with adjusted earnings of $1.80 per share on revenue of $11.2 billion. This revenue figure represents a 6% year-over-year decrease compared to the same period last year, when the company recorded a loss